Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Exercise for Brain Health

Start: October 8, 2018
End: April 2024
Enrollment: 152

What Is This Study About?

This study is recruiting older adults who are cognitively healthy but physically inactive to participate in an intervention comparing aerobic exercise and flexibility exercise and their effects on memory and brain function. Participants will engage in either moderate-intensity aerobic exercise, including treadmill walking, or flexibility exercise for four days per week for six months. Group-based exercise classes will take place in local retirement communities near College Park, MD, or at the University of Maryland, College Park. Researchers will measure changes in memory performance, MRI biomarkers, and fitness.

Do I Qualify To Participate in This Study?

Minimum Age: 60 Years

Maximum Age: 80 Years

Must have:

  • Fluent in English
  • Physically active two or fewer days per week for the past six months
  • Physician consent to undergo an exercise stress test and engage in moderate-intensity exercise
  • Ability to undergo magnetic resonance imaging

Must NOT have:

  • Neurological conditions such as cerebral palsy, epilepsy, brain tumor, chronic meningitis, multiple sclerosis, pernicious anemia, normal-pressure hydrocephalus, HIV infection, Parkinson's disease, and Huntington's disease
  • Untreated high blood pressure, glaucoma, or chronic obstructive pulmonary disease
  • Untreated severe major depression
  • Substance abuse or dependence
  • Use of psychoactive medications, except selective serotonin/norepinephrine reuptake inhibitor antidepressants
  • Use of acetylcholinesterase inhibitors, including Alzheimer's medications donepezil, rivastigmine, and galantamine
  • Unstable or severe heart disease or asthmatic condition
  • History of transient ischemic attack, cerebral ischemia, or stroke
  • Diagnosis of mild cognitive impairment or dementia, or objective evidence of cognitive impairment

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Study Contact
Study Coordinator

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

University of Maryland, Department of Kinesiology
College Park, MD 20742
Study Coordinator

Who Sponsors This Study?

Lead: University of Maryland

Collaborator Sponsor

  • National Institute on Aging (NIA)
  • Johns Hopkins University
  • Marquette University

Source: ID: NCT03727360

An official website of the U.S. government, managed by the National Institutes on Aging at the National Institutes of Health